Skip to main content

IRADIMED CORP

corporate_fare Company Profile

IRADIMED CORP

IRMD·NASDAQ·Industrial Applications And Services·CIK 0001325618

IRADIMED CORPORATION develops, manufactures, markets, and distributes Magnetic Resonance Imaging (MRI) compatible medical devices and related accessories, disposables, and services. The company was originally incorporated in Oklahoma in 1992 as IRI Development, Inc., and merged into the newly formed Delaware corporation, IRADIMED CORPORATION, in April 2014. IRADIMED is the sole known provider of a non-magnetic intravenous (IV) infusion pump system, the MRidium® 3870 MRI Compatible IV Infusion Pump System, which is specifically designed for safe use during MRI procedures and operates reliably in magnetic fields up to 15,000 gauss. This system, introduced in 2025, was the first infusion delivery system to address many dangers and problems associated with MRI procedures. Standard infusion pumps contain magnetic and electronic components that can cause radio frequency interference and are hazardous near MRI magnets. The patented MRidium 3870 system features a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and a touch screen user interface to safely and predictably deliver anesthesia and other critical care IV fluids during various MRI procedures. This solution ensures accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is crucial for critically ill patients requiring continuous medication and for children and infants needing sedation for immobility during scans. The MRidium 3870 IV Infusion Pump System includes the MRidium 3870 MRI Compatible IV Infusion Pump, a non-magnetic IV pole mounting system, a non-magnetic mobile IV pole stand, proprietary disposable IV tubing sets, and other options like a Remote Display Unit.

IRADIMED CORP (NASDAQ:IRMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for IRMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-30, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for IRMD spans 10-Q, 8-K, 144, 10-K.

Recent high-impact activity:

  • iRadimed 10-Q Details Record Q3: $24.2M Revenue, $0.51 EPS, $0.20 Dividend
  • iRadimed Posts Record $24.2M Q3 Revenue, Narrows Full-Year Guidance and Declares $0.20 Dividend
  • iRadimed Posts 51-Cent Q3 EPS, Topping Prior Quarter's 41 Cents
  • iRadimed Launches New 3870 MR IV Pump, Guides Q3 Revenue Up 12-20%
  • IRADIMED Q2 2026: Revenue Meets Mark, EPS Slips; Full-Year Outlook Holds Steady

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$83.81M
Net Income
$22.48M
Diluted EPS
$1.75
Op. Cash Flow
$24.95M
Free Cash Flow
$17.18M
Gross Profit
$64.32M
Operating Income
$26.15M
Cash & Equivalents
$51.16M
Debt / Equity
0.00×
Net Margin
26.8%
Shares Outstanding
12.78M sh
Source: 10-K · filed 2026-03-06 · accession 0001104659-26-024691

Short Interest & Short Volume

5.10 days to cover

FINRA reported short interest of 590,054 shares in IRMD as of the October 30, 2026 settlement, a 12.0% decrease from the prior period — about 5.1 days to cover at its recent average daily volume. On November 20, 2026, 63.0% of IRMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)590,054 shares as of October 30, 2026
Change vs prior period▼ 12.0%
Days to cover5.10 at avg daily volume of 115,775
Daily short volume (FINRA facilities)63.0% of 32,330 shares on November 20, 2026
5-day average short volume55.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with I →
$81.02
52-week range · as of 2026-10-30 $75.75 – $107.9
Market cap
$1.04B
Volume
101.3K (0.9× avg)
3-mo avg 117.2K
Live data · 2026-11-21 05:56 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed IRMD - Latest Insights

IRMD
Oct 30, 2026, 4:16 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $76.40
Real-time Price: $81.02 info
Change: +$4.62 (+6%) info
Market Cap: $1.036B info
IRMD
Oct 30, 2026, 8:37 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $83.50
Real-time Price: $81.02 info
Change: -$2.48 (-3%) info
Market Cap: $1.036B info
IRMD
Oct 30, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $83.50
Real-time Price: $81.02 info
Change: -$2.48 (-3%) info
Market Cap: $1.036B info
IRMD
Aug 21, 2026, 5:48 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $87.85
Real-time Price: $81.02 info
Change: -$6.83 (-8%) info
Market Cap: $1.036B info
IRMD
Jul 31, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $95.21
Real-time Price: $81.02 info
Change: -$14.19 (-15%) info
Market Cap: $1.036B info
IRMD
Jul 31, 2026, 8:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $95.21
Real-time Price: $81.02 info
Change: -$14.19 (-15%) info
Market Cap: $1.036B info
IRMD
May 01, 2026, 4:08 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $87.15
Real-time Price: $81.02 info
Change: -$6.13 (-7%) info
Market Cap: $1.036B info
IRMD
May 01, 2026, 8:45 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $83.00
Real-time Price: $81.02 info
Change: -$1.98 (-2%) info
Market Cap: $1.036B info
IRMD
May 01, 2026, 8:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $83.00
Real-time Price: $81.02 info
Change: -$1.98 (-2%) info
Market Cap: $1.036B info
IRMD
Mar 06, 2026, 4:24 PM EST
Filing Type: 144
Importance Score:
9
Price at Filing: $98.72
Real-time Price: $81.02 info
Change: -$17.70 (-18%) info
Market Cap: $1.036B info
IRMD
Mar 06, 2026, 4:05 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $98.72
Real-time Price: $81.02 info
Change: -$17.70 (-18%) info
Market Cap: $1.036B info
IRMD
Feb 10, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $95.97
Real-time Price: $81.02 info
Change: -$14.95 (-16%) info
Market Cap: $1.036B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets